United Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. 

CEO
Martine A. Rothblatt
CEOMartine A. Rothblatt
Employees
1,400
Employees1,400
Headquarters
Silver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded
1996
Founded1996
Employees
1,400
Employees1,400

UTHR Key Statistics

Market cap
23.94B
Market cap23.94B
Price-Earnings ratio
21.20
Price-Earnings ratio21.20
Dividend yield
—
Dividend yield—
Average volume
541.08K
Average volume541.08K
High today
$569.45
High today$569.45
Low today
$559.41
Low today$559.41
Open price
$561.11
Open price$561.11
Volume
468.56K
Volume468.56K
52 Week high
$614.23
52 Week high$614.23
52 Week low
$444.04
52 Week low$444.04

Stock Snapshot

With a market cap of 23.94B, United Therapeutics(UTHR) trades at $562.02. The stock has a price-to-earnings ratio of 21.20.

During the trading session on 2026-11-08, United Therapeutics(UTHR) shares reached a daily high of $569.45 and a low of $559.41. At a current price of $562.02, the stock is +0.5% higher than the low and still -1.3% under the high.

Trading activity shows a volume of 468.56K, compared to an average daily volume of 541.08K.

Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $614.23 and a low of $444.04.

Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $614.23 and a low of $444.04.

UTHR News

Simply Wall St 1d
Is United Therapeutics Undervalued On Earnings And Its $2b Buyback? - Simply Wall St

...

Is United Therapeutics Undervalued On Earnings And Its $2b Buyback? - Simply Wall St
TipRanks 4d
United Therapeutics Earnings Call Signals Stronger Growth

United Therapeutics Corp. ((UTHR)) has held its Q3 earnings call. Read on for the main highlights of the call. United Therapeutics’ earnings call conveyed stro...

Analyst ratings

82%

of 17 ratings
Buy
82.4%
Hold
11.8%
Sell
5.9%

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.